Finance

Lists
532488:BOM
Divi's Laboratories Ltd
9 220,00 ₹
+1,99%
(+180,05) 1D
16 қаз., 15:56:15 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532488...
Open
9 013,35 ₹
High
9 247,50 ₹
Low
8 985,00 ₹
Mkt. cap
2,45 трлн
Avg. vol.
33,69 мың
Volume
17,22 мың
Dividend
0,33%
Quarterly dividend
7,50 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
83,67
52-wk high
10 000,00 ₹
52-wk low
5 648,00 ₹
EPS
110,20 ₹
Shares outstanding
265,47 млн
No. of employees
12 мың
Open
9 013,35 ₹
High
9 247,50 ₹
Low
8 985,00 ₹
Mkt. cap
2,45 трлн
Avg. vol.
33,69 мың
Volume
17,22 мың
Dividend
0,33%
Quarterly dividend
7,50 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
83,67
52-wk high
10 000,00 ₹
52-wk low
5 648,00 ₹
EPS
110,20 ₹
Shares outstanding
265,47 млн
No. of employees
12 мың
News stories
From web sources and news partners
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11,6 мың
Founded1990 ж. 12 қаз.
Headquarters-
Sector-
Websitedivislabs.com
Last report
2026 ж. 01 там.
Fiscal period
Q1 2027
33,95 ₹ / 24,68 ₹
+37,58%beat
Revenue / Est. (INR)
30,80 млрд / 27,61 млрд
+11,56%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
27,15 млрд
26,04 млрд
28,31 млрд
30,80 млрд
Cost of goods sold
10,73 млрд
9,45 млрд
13,49 млрд
9,86 млрд
Cost of revenue
10,73 млрд
9,45 млрд
13,49 млрд
9,86 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,54 млрд
3,67 млрд
3,99 млрд
4,08 млрд
Operating expense
8,67 млрд
8,87 млрд
6,68 млрд
9,65 млрд
Total operating expenses
19,40 млрд
18,32 млрд
20,17 млрд
19,51 млрд
Operating income
7,75 млрд
7,72 млрд
8,14 млрд
11,29 млрд
Other non operating income
820,00 млн
690,00 млн
-2,23 млрд
640,00 млн
EBT including unusual items
9,12 млрд
7,80 млрд
9,63 млрд
11,80 млрд
EBT excluding unusual items
9,12 млрд
8,54 млрд
9,59 млрд
11,80 млрд
Income tax expense
2,23 млрд
1,97 млрд
2,12 млрд
2,78 млрд
Effective tax rate
24,45%
25,26%
22,01%
23,56%
Other operating expenses
4,00 млрд
4,02 млрд
1,49 млрд
4,24 млрд
Net income
6,89 млрд
5,83 млрд
7,51 млрд
9,02 млрд
Net profit margin
25,38%
22,39%
26,53%
29,29%
Earnings per share
25,97
24,07
28,31
33,95
Interest and investment income
-
-
2,84 млрд
-
Interest expense
-80,00 млн
-60,00 млн
-60,00 млн
-60,00 млн
Net interest expenses
-80,00 млн
-60,00 млн
2,78 млрд
-60,00 млн
Depreciation and amortization charges
1,13 млрд
1,18 млрд
1,20 млрд
1,33 млрд
EBITDA
8,88 млрд
8,72 млрд
9,29 млрд
12,44 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары